Alerts will be sent to your verified email
Verify EmailZYDEN
|
Zyden Gentec
|
Hind Bio Science
|
Adline Chem Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-24.76 % | -24.99 % | 51.73 % |
|
5yr average Equity Multiplier
|
2.0 | 3.76 | 0.93 |
|
5yr Average Asset Turnover Ratio
|
0.21 | 0.25 | 0.25 |
|
5yr Avg Net Profit Margin
|
-137.59 % | -39.56 % | 15.43 % |
|
Price to Book
|
n/a | 6.98 | 0.0 |
|
P/E
|
n/a | 263.1 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
785.76 Days | 197.57 Days | 0.0 |
|
Inventory Days
|
134.34 Days | 0.0 | 40.82 Days |
|
Days Receivable
|
803.05 Days | 198.39 Days | 0.0 |
|
Days Payable
|
421.99 Days | 104.32 Days | 61.52 Days |
|
5yr Average Interest Coverage Ratio
|
-2.08 | -32.49 | 10.45 |
|
5yr Avg ROCE
|
-6.92 % | -14.28 % | -27.86 % |
|
5yr Avg Operating Profit Margin
|
-95.87 % | -38.68 % | -8.78 % |
|
5 yr average Debt to Equity
|
0.68 | 2.68 | -0.21 |
|
5yr CAGR Net Profit
|
-1.66 % | n/a | -37.71 % |
|
5yr Average Return on Assets
|
-15.88 % | -8.2 % | -1534.04 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 12.19 % | 29.61 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-17.28 % | 0.0 | 1.37 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Zyden Gentec
|
Hind Bio Science
|
Adline Chem Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|